Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
SBC Medical Group Holdings Incorporated, a Nasdaq-listed U.S. medical services company, announced the opening of a new aesthetic dermatology section at BLEZ CLINIC in Bangkok through its consulting partner BLEZ ASIA. The new section, launching services in June 2026, will offer Japanese-standard aesthetic treatments such as pico laser for pigmentati…
Black Diamond Therapeutics announced that CEO Mark Velleca will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York on June 3, 2026. The company plans one-on-one investor meetings and will webcast the presentation, highlighting its clinical-stage oncology focus on innovative MasterKey therapies targeting oncogen…
SunPower Inc. has closed an additional $5 million private placement on its April senior convertible debenture notes, bringing total funding to $46 million. The funds will support intra-quarter liquidity for general corporate purposes. The company is focused on reducing overhead costs from prior acquisitions and aims to achieve steady-state cashflow…
ABM Industries Incorporated announced the release of its fiscal second quarter 2026 financial results on June 5, 2026, prior to market opening. The company will host a conference call and webcast for investors to discuss the results, with a replay available for 90 days. ABM is a leading provider of integrated facility solutions serving diverse sect…
Anavex Life Sciences Corp., a clinical-stage biopharmaceutical company, received a notification from Nasdaq regarding non-compliance with listing rules due to the late filing of its Form 10-Q for the quarterly period ending March 31, 2026. The company has until July 20, 2026, to submit a plan to regain compliance and is currently working to complet…
BitFuFu Inc., a leading Bitcoin mining company listed on NASDAQ under ticker FUFU, announced it will release its unaudited financial results for the first quarter of 2026 on May 29, 2026, before the U.S. market opens. The management will hold an earnings conference call the same day to discuss the results. The company specializes in Bitcoin mining …
Sun Pharmaceutical Industries reported a March-quarter net profit slightly above analyst expectations, driven by growth in its specialty therapies franchise. However, rising costs - notably in research and development - pushed expenses sharply higher and compressed core margins, prompting a drop in the company's share price despite the profit beat.
JPMorgan has put Dick’s Sporting Goods on a Positive Catalyst Watch ahead of the retailer’s first-quarter 2026 earnings, lifting comparable-sales and earnings projections above Wall Street consensus. The bank’s note from analyst Christopher Horvers increases Dick’s core comp estimate and turns Foot Locker comps positive, while modeling a significan…
U.S. stock futures were mostly higher on Friday morning as investors monitored media reports about potential talks aimed at ending the conflict in Iran. Major premarket movers included Take-Two Interactive, Workday, Zoom and Estee Lauder, driven by quarterly results, product launch timelines and the end of merger discussions. Chipmakers and quantum…
Goldman Sachs finds that recent US economic indicators have outperformed comparable measures in the UK and Euro area. The US composite PMI has stayed broadly stable since February while the UK and Euro area readings have declined by roughly 4-5 points. The firm links the divergence to uneven growth impacts from the energy shock and also highlights …
Zymeworks ($ZYME) combines royalty revenue from licensed assets with a deep antibody-drug conjugate (ADC) pipeline that now carries real clinical momentum. The market prices the company like a high-growth commercial biopharma at a $1.85B market cap, but cash-like royalties, recent leadership hires aligned with deal execution, and Fast Track status …
Repligen Corporation, a leader in bioprocessing technologies, announced its participation in the William Blair 46th Annual Growth Stock Conference with a presentation by its CEO on June 3rd. The presentation will provide a company overview and highlight its focus on innovative bioprocessing technologies supporting biological drug manufacturing.
BriaCell Therapeutics announced positive clinical data from its Phase 2 and ongoing Phase 3 studies evaluating Bria-IMT immunotherapy in heavily pre-treated metastatic breast cancer patients. The data highlighted median overall survival improvements, preserved quality of life, and biomarker analyses supporting predictors of response. No safety conc…
April residential construction figures from the Census Bureau point to a housing market that remains resilient overall but shows softness in single-family construction. Multifamily starts provided year-over-year gains that lifted total starts, while permitting and single-family metrics weakened. DA Davidson kept Buy ratings and Top Pick designation…
U.S. equity funds saw a second weekly outflow in nine weeks during the week ended May 20 as investors took profits after a rally and expressed caution about rising inflation and a sharp increase in long-term borrowing costs. LSEG Lipper data show $12.05 billion in net redemptions from U.S. equity funds, while bond and money market funds attracted s…
The Dow climbed to a fresh high while Asian chip shares extended gains after demand signals from Nvidia, underscoring continued investor appetite for AI-related exposure. At the same time, mixed reports on U.S.-Iran negotiations have constrained broader market conviction, leaving U.S. futures largely rangebound. Separately, a set of AI-powered scre…
Pfizer is trading at a reasonable valuation with a 6.7% yield, solid free cash flow and manageable leverage. Political talk of aggressive drug pricing reform has cooled, and the company’s pipeline (notably pneumococcal vaccines) plus accretive M&A optionality give a clear path to upside. We recommend a mid-term long with an entry at current levels,…
The dual-class share arrangement disclosed in SpaceX’s IPO filing, which would give CEO Elon Musk outsized voting control, has refocused attention on a longstanding corporate governance dispute. Advocates say stronger founder control shields long-term strategy from short-term market pressures, while opponents argue it concentrates power and can wea…
Barclays says European equities could see a rapid rebound should the Iran conflict be resolved swiftly, but warns of significant downside if disruptions to the Strait of Hormuz persist. The bank frames the relative performance of EU versus U.S. stocks as increasingly dependent on the path of oil prices, noting deteriorating eurozone macro signals a…
Flowers Foods' recent dividend reset and ugly near-term earnings have already been priced into the shares. The cut reduces cash bleed, gives management breathing room after the Simple Mills acquisition and a fiscal 2026 loss, and leaves the stock trading at cheap multiples and an oversold technical profile. I view this as a tactical long: enter at …
Assembly Biosciences, a Nasdaq-listed biotechnology company, announced the pricing of a $100 million offering of common stock and pre-funded warrants. The proceeds are intended to support the clinical development of its pipeline candidates targeting serious viral and liver diseases. The offering attracted participation from new and existing investo…
Regeneron Pharmaceuticals announced that the European Medicines Agency (EMA) has accepted for review under Accelerated Assessment the Marketing Authorization Application for Otarmeni™ (lunsotogene parvec), a gene therapy for biallelic OTOF variant-associated hearing loss. Otarmeni is already approved in the U.S. and this approval could mark the fir…
American Shared Hospital Services (NYSE American: AMS), a provider of stereotactic radiosurgery and advanced radiation therapy services, announced its 2026 Annual Shareholder Meeting to be held virtually on June 24, 2026. Shareholders of record on April 27, 2026, are eligible to participate and vote. The company continues to focus on expanding inte…
Assembly Biosciences, Inc. announced the expansion of its clinical development program for ABI-6250, an oral entry inhibitor originally targeted for chronic hepatitis delta virus (HDV) infection, to include primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC). A Phase 2 study focusing on these cholestatic liver diseases is exp…
Chagee Holdings Limited, a premium tea drinks brand listed on NASDAQ under the ticker CHA, announced it will report its first quarter 2026 financial results on May 28, 2026. The company will hold a conference call to discuss the results and engage with investors, continuing its commitment to transparency and communication.
